Acute disseminated encephalomyelitis risk factors

Jump to navigation Jump to search
The printable version is no longer supported and may have rendering errors. Please update your browser bookmarks and please use the default browser print function instead.

Acute disseminated encephalomyelitis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Acute disseminated encephalomyelitis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Acute disseminated encephalomyelitis risk factors On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Acute disseminated encephalomyelitis risk factors

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Acute disseminated encephalomyelitis risk factors

CDC on Acute disseminated encephalomyelitis risk factors

Acute disseminated encephalomyelitis risk factors in the news

Blogs on Acute disseminated encephalomyelitis risk factors

Directions to Hospitals Treating Acute disseminated encephalomyelitis

Risk calculators and risk factors for Acute disseminated encephalomyelitis risk factors

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sujaya Chattopadhyay, M.D.[2]

Overview

The risk factors for ADEM include:

Risk Factors

Infections

Vaccinations

Genetic susceptibility

References

  1. Hung KL, Liao HT, Tsai ML (2001). "The spectrum of postinfectious encephalomyelitis". Brain Dev. 23 (1): 42–5. doi:10.1016/s0387-7604(00)00197-2. PMID 11226729.
  2. Berzero G, Cortese A, Ravaglia S, Marchioni E (2016). "Diagnosis and therapy of acute disseminated encephalomyelitis and its variants". Expert Rev Neurother. 16 (1): 83–101. doi:10.1586/14737175.2015.1126510. PMID 26620160.
  3. Berzero G, Cortese A, Ravaglia S, Marchioni E (2016). "Diagnosis and therapy of acute disseminated encephalomyelitis and its variants". Expert Rev Neurother. 16 (1): 83–101. doi:10.1586/14737175.2015.1126510. PMID 26620160.
  4. Berzero G, Cortese A, Ravaglia S, Marchioni E (2016). "Diagnosis and therapy of acute disseminated encephalomyelitis and its variants". Expert Rev Neurother. 16 (1): 83–101. doi:10.1586/14737175.2015.1126510. PMID 26620160.
  5. Menge T, Hemmer B, Nessler S, Wiendl H, Neuhaus O, Hartung HP; et al. (2005). "Acute disseminated encephalomyelitis: an update". Arch Neurol. 62 (11): 1673–80. doi:10.1001/archneur.62.11.1673. PMID 16286539.
  6. Esposito S, Di Pietro GM, Madini B, Mastrolia MV, Rigante D (2015). "A spectrum of inflammation and demyelination in acute disseminated encephalomyelitis (ADEM) of children". Autoimmun Rev. 14 (10): 923–9. doi:10.1016/j.autrev.2015.06.002. PMC 7105213 Check |pmc= value (help). PMID 26079482.
  7. Esposito S, Di Pietro GM, Madini B, Mastrolia MV, Rigante D (2015). "A spectrum of inflammation and demyelination in acute disseminated encephalomyelitis (ADEM) of children". Autoimmun Rev. 14 (10): 923–9. doi:10.1016/j.autrev.2015.06.002. PMC 7105213 Check |pmc= value (help). PMID 26079482.
  8. 8.0 8.1 Huynh W, Cordato DJ, Kehdi E, Masters LT, Dedousis C (2008). "Post-vaccination encephalomyelitis: literature review and illustrative case". J Clin Neurosci. 15 (12): 1315–22. doi:10.1016/j.jocn.2008.05.002. PMC 7125578 Check |pmc= value (help). PMID 18976924.
  9. Imbesi D, Calabrò RS, Gervasi G, Casella C, Vita G, Musolino R (2012). "Does HLA Class II haplotype play a role in adult acute disseminated encephalomyelitis? Preliminary findings from a Southern Italy hospital-based study". Arch Ital Biol. 150 (1): 1–4. doi:10.4449/aib.v150i1.1384. PMID 22786832.
  10. Bergamaschi R, Livieri C, Uggetti C, Candeloro E, Egitto MG, Pichiecchio A; et al. (2006). "Brain white matter impairment in congenital adrenal hyperplasia". Arch Neurol. 63 (3): 413–6. doi:10.1001/archneur.63.3.413. PMID 16540460.